Ohio State had $292.3 million in total operating expenses during its 2024 fiscal year, according to its new annual revenue-and-expenses report to the NCAA. Not adjusting for inflation, the total is ...

Florida’s athletic department topped $200 million in operating revenues during its 2024 fiscal year, but spent nearly as much, according to its financial report to the NCAA. Athletic programs for the ...

Adjusted EBITDA is defined as earnings before net interest expense, income taxes, depreciation, amortization and accretion expense, allocated non-cash compensation expense, unrealized gains and losses ...

The National Association of Real Estate Investment Trusts (“NAREIT”), an industry trade group, has promulgated a widely accepted non-GAAP financial measure of operating performance known as FFO. Our ...

(1) Adjusted EBITDA, total debt at maturity and net debt less total unamortized discount are not financial measures calculated or presented in accordance with accounting principles generally accepted ...

Baylor Scott & White boosted its operating margin to 11.3% in Q1 fiscal 2026, driven by revenue growth and improved payer mix.

The results were detailed in a Nov. 6 presentation to a Penn Board of Trustees committee by UPHS chief financial officer ...

Oakland, Calif.-based Kaiser Permanente posted an operating income of $569 million (0.5% operating marin) in 2024, up from an operating income of $329 million (0.3% margin) in 2023, according to its ...

Reduced total and Net Debt 1 by $145.0 million and $133.5 million, respectively, through free cash flow, net changes in working capital, and the sale of non-core assets Reported a net loss of $18.8 ...

A report found Victoria recorded an operating loss of $2.6 billion in 2024-25, adding to accumulated losses of $50.6 billion ...

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced financial results for the second ...

MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative ...